ROIV
Roivant Sciences·NASDAQ
--
--(--)
--
--(--)
ROIV fundamentals
Roivant Sciences (ROIV) released its earnings on Feb 6, 2026: revenue was 2.00M (YoY -77.82%), missed estimates; EPS was -0.17 (YoY -173.91%), beat estimates.
Revenue / YoY
2.00M
-77.82%
EPS / YoY
-0.17
-173.91%
Report date
Feb 6, 2026
ROIV Earnings Call Summary for Q3,2026
- Breakthrough Sarcoidosis Data: Brepocitinib achieved 21.6-point CSAMI improvement, 100% high-dose responders, and no safety surprises in Phase II.
- Pipeline Momentum: 9+ pivotal studies readouts in 2026, including PH-ILD, D2T RA, and Graves' disease.
- Financial Strength: $4.5B cash, no near-term capital needs despite ~$300M annual R&D spend.
- Strategic Focus: Orphan inflammation leadership with brepocitinib (3 Phase III programs) and FcRn franchise (IMVT-1402).
EPS
Revenue
Revenue & Expenses
ROIV has released its 2026 Q2 earnings report, with revenue of 1.57M, reflecting a YoY change of -64.89%, and net profit of -166.04M, showing a YoY change of 40.68%. The Sankey diagram below clearly presents ROIV's revenue sources and cost distribution.
Key Indicators
Roivant Sciences (ROIV) key financial stats and ratios, covering profitability, financial health, and leverage.
Roivant Sciences (ROIV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Roivant Sciences (ROIV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Roivant Sciences (ROIV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Roivant Sciences (ROIV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Roivant Sciences (ROIV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Roivant Sciences's revenue and profit?What is the market's earnings forecast for Roivant Sciences next quarter?What does Roivant Sciences do and what are its main business segments?What were the key takeaways from Roivant Sciences's earnings call?Did Roivant Sciences beat or miss consensus estimates last quarter?What is Roivant Sciences's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Roivant Sciences year over year?What guidance did Roivant Sciences's management provide for the next earnings period?
